SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Spartan Delta Corp. (DALXF) trades at a trailing P/E of 24.4, forward P/E of 16.8. Trailing earnings yield is 4.10%, forward earnings yield 5.96%. PEG 0.35 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (24.4); PEG ≤ 1.0 — Peter Lynch undervalued (0.35); earnings yield beats bond yields (4.10%).
- Forward P/E 16.8 (down from trailing 24.4) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 0.35 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 4.10% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 5.96% as earnings recover.
Overall SharesGrow Score: 66/100 with 4/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — DALXF
Valuation Multiples
P/E (TTM)24.4
Forward P/E16.8
PEG Ratio0.35
Forward PEG0.37
P/B Ratio0.00
P/S Ratio4.55
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.34
Forward EPS (Est.)$0.50
Book Value / Share$0.00
Revenue / Share$1.82
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.10%
Forward Earnings Yield5.96%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-2.77 |
$529.37K |
$-391.32K |
-73.9% |
| 2017 |
$-5.63 |
$2.24M |
$-2.25M |
-100.4% |
| 2018 |
$-2.85 |
$2.03M |
$-3.16M |
-155.2% |
| 2019 |
$-1.00 |
$1.65M |
$-2M |
-121.1% |
| 2020 |
$0.86 |
$99.71M |
$47.66M |
47.8% |
| 2021 |
$2.50 |
$618.84M |
$334.22M |
54% |
| 2022 |
$3.88 |
$1.48B |
$681.09M |
46.2% |
| 2023 |
$3.82 |
$662.36M |
$663.11M |
100.1% |
| 2024 |
$0.20 |
$307.26M |
$34.28M |
11.2% |
| 2025 |
$0.34 |
$369.67M |
$69.96M |
18.9% |
